Cover Image
市場調查報告書

尿液檢查:開發平台分析

Urine Analysis - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 341583
出版日期 內容資訊 英文 61 Pages
訂單完成後即時交付
價格
Back to Top
尿液檢查:開發平台分析 Urine Analysis - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年07月01日 內容資訊: 英文 61 Pages
簡介

本報告提供全球各國的企業·醫療機關等正在開發的尿液檢查之開發中產品資訊分析,提供您臨床實驗與產品開發的進展,各階段·各市場區隔·國家 (地區) 別趨勢,企業與產品詳細資訊,最近的產品開發及產業趨勢等資訊。

第1章 目錄

第2章 簡介

  • 尿液檢查概要

第3章 開發中的產品

  • 尿液檢查 - 各開發階段的開發中產品
  • 尿液檢查 - 各市場區隔的開發中產品
  • 尿液檢查 -國家 (地區) 別的開發中產品
  • 尿液檢查 - 法規別的開發中產品
  • 尿液檢查 - 核准時期 (估計) 別的開發中產品
  • 尿液檢查 - 現在進行中的臨床實驗

第4章 尿液檢查 - 正在開發的開發中產品:各企業

  • 尿液檢查企業 - 各開發階段的開發中產品
  • 尿液檢查 - 各開發階段的開發中產品

第5章 尿液檢查企業與產品概要

  • Analyticon Biotechnologies AG
  • Arkray, Inc.
  • Biosense Technologies Pvt Ltd.
  • California Pacific Medical Center Research Institute
  • Erba Diagnostics, Inc.
  • Imagnus Biomedical Inc.
  • Imperial College London
  • IRIS International, Inc.
  • LifeAssays AB
  • Roche Diagnostics International Ltd.
  • Scanadu HQ
  • Shenzhen Genius Electronics Co., Ltd.
  • Siemens Healthcare Diagnostics Inc.
  • Stanford University
  • Svenska Cellulosa Aktiebolaget
  • Sysmex
  • Teco Diagnostics
  • University of California, San Francisco
  • University of Kentucky
  • University of Maryland, Baltimore

第6章 尿液檢查 - 最近的趨勢

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's Medical Devices sector report, "Urine Analysis - Medical Devices Pipeline Assessment, 2017" provides an overview of Urine Analysis currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Urine Analysis pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Urine Analysis under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Urine Analysis and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Urine Analysis under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 5

2 Introduction 6

  • 2.1 Urine Analysis Overview 6

3 Products under Development 7

  • 3.1 Urine Analysis - Pipeline Products by Stage of Development 7
  • 3.2 Urine Analysis - Pipeline Products by Segment 8
  • 3.3 Urine Analysis - Pipeline Products by Territory 9
  • 3.4 Urine Analysis - Pipeline Products by Regulatory Path 10
  • 3.5 Urine Analysis - Pipeline Products by Estimated Approval Date 11
  • 3.6 Urine Analysis - Ongoing Clinical Trials 12

4 Urine Analysis - Pipeline Products under Development by Companies 13

  • 4.1 Urine Analysis Companies - Pipeline Products by Stage of Development 13
  • 4.2 Urine Analysis - Pipeline Products by Stage of Development 14

5 Urine Analysis Companies and Product Overview 15

  • 5.1 Analyticon Biotechnologies AG Company Overview 15
    • 5.1.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 15
  • 5.2 Biosense Technologies Pvt Ltd. Company Overview 16
    • 5.2.1 Biosense Technologies Pvt Ltd. Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.3 California Pacific Medical Center Research Institute Company Overview 17
    • 5.3.1 California Pacific Medical Center Research Institute Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.4 Erba Diagnostics, Inc. Company Overview 18
    • 5.4.1 Erba Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.5 Imperial College London Company Overview 19
    • 5.5.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.6 IRIS International Inc Company Overview 20
    • 5.6.1 IRIS International Inc Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.7 LifeAssays AB Company Overview 21
    • 5.7.1 LifeAssays AB Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.8 Roche Diagnostics International Ltd Company Overview 22
    • 5.8.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.9 Scanadu HQ Company Overview 23
    • 5.9.1 Scanadu HQ Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.10 Sebia SA Company Overview 26
    • 5.10.1 Sebia SA Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.11 Siemens Healthcare GmbH Company Overview 28
    • 5.11.1 Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.12 Stanford University Company Overview 29
    • 5.12.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.13 Sysmex Corp Company Overview 30
    • 5.13.1 Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.14 Teco Diagnostics Company Overview 33
    • 5.14.1 Teco Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.15 Trinity College Dublin Company Overview 34
    • 5.15.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.16 University of Kentucky Company Overview 35
    • 5.16.1 University of Kentucky Pipeline Products & Ongoing Clinical Trials Overview 35

6 Urine Analysis- Recent Developments 36

  • 6.1 May 21, 2017: Sysmex New Zealand Commence Direct Sales of Urinalysis Instrument Portfolio 36
  • 6.2 May 10, 2017: Streck signs distribution agreement with Genomax Technologies 36
  • 6.3 May 04, 2017: Bio-Rad Reports First-Quarter 2017 Financial Results 37
  • 6.4 May 02, 2017: Sphere Medical Holding: Commercialisation Update 38
  • 6.5 Apr 10, 2017: Streck signs distribution agreement with RUWAG Diagnostics 38
  • 6.6 Apr 03, 2017: Sysmex Establishes New Company, Sysmex Harmony, to Promote the Employment of People with Disabilities 39
  • 6.7 Mar 31, 2017: HORIBA Instruments commences operations at new factory in Houston 39
  • 6.8 Mar 29, 2017: Sysmex America Announces Leadership Promotions 41
  • 6.9 Mar 20, 2017: EKF Diagnostics Holdings: Final results 41
  • 6.10 Mar 13, 2017: Bio-Rad Intends to Propose Three New Independent Directors 42
  • 6.11 Mar 13, 2017: Bio-Rad Initiates Long Term Financial Guidance; Commits to Defining Long Term Capital Allocation Targets and Hosting an Annual Investor Day 43
  • 6.12 Feb 23, 2017: VBio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results 44
  • 6.13 Feb 23, 2017: Bio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results 46
  • 6.14 Feb 22, 2017: U.S. ARKRAY announces the launch of the AUTION ELEVEN AE-4022 Semi-Automated Urine Analyzer 48
  • 6.15 Feb 01, 2017: Streck signs distribution agreement with HiSS Diagnostics 48
  • 6.16 Dec 15, 2016: Next generation Proxima launched 49
  • 6.17 Nov 29, 2016: ERBA Diagnostics names interim CEO 50
  • 6.18 Nov 01, 2016: Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 9.1 Percent 50
  • 6.19 Oct 17, 2016: New design of hematology and clinical chemistry analyzers 51
  • 6.20 Oct 13, 2016: Eric Riley joins Streck as Human Resources Director 52
  • 6.21 Sep 30, 2016: Proxima 4 CE mark achieved 52
  • 6.22 Sep 12, 2016: EKF Diagnostics Holdings: Half-year Report 53
  • 6.23 Aug 03, 2016: Bio-Rad Reports Second-Quarter 2016 Financial Results 55
  • 6.24 Jul 21, 2016: Sphere Medical Holding: Appointment of Regional Distributor and Company Update 56
  • 6.25 Jul 11, 2016: EKF Diagnostics Holdings Appoints Carl Dominic Contadini As Non-Executive Director 57

7 Appendix 58

  • 7.1 Methodology 58
  • 7.2 About GlobalData 61
  • 7.3 Contact Us 61
  • 7.4 Disclaimer 61

List of Tables

1.1 List of Tables

  • Table 1: Urine Analysis - Pipeline Products by Stage of Development 7
  • Table 2: Urine Analysis - Pipeline Products by Segment 8
  • Table 3: Urine Analysis - Pipeline Products by Territory 9
  • Table 4: Urine Analysis - Pipeline Products by Regulatory Path 10
  • Table 5: Urine Analysis - Pipeline Products by Estimated Approval Date 11
  • Table 6: Urine Analysis - Ongoing Clinical Trials 12
  • Table 7: Urine Analysis Companies - Pipeline Products by Stage of Development 13
  • Table 8: Urine Analysis - Pipeline Products by Stage of Development 14
  • Table 9: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 15
  • Table 10: CombiScan XL - Product Status 15
  • Table 11: CombiScan XL - Product Description 15
  • Table 12: Biosense Technologies Pvt Ltd. Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 13: uChek Universal - Product Status 16
  • Table 14: uChek Universal - Product Description 16
  • Table 15: California Pacific Medical Center Research Institute Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 16: Urinary Proteome Monitoring Assay - Product Status 17
  • Table 17: Urinary Proteome Monitoring Assay - Product Description 17
  • Table 18: Erba Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 19: Laura XL - Product Status 18
  • Table 20: Laura XL - Product Description 18
  • Table 21: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 22: Diagnostic Test - Autism - Product Status 19
  • Table 23: Diagnostic Test - Autism - Product Description 19
  • Table 24: IRIS International Inc Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 25: 3GEMS Next Generation Urinalysis Platform - Product Status 20
  • Table 26: 3GEMS Next Generation Urinalysis Platform - Product Description 20
  • Table 27: LifeAssays AB Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 28: LifeAssays U-Albumin - Product Status 21
  • Table 29: LifeAssays U-Albumin - Product Description 21
  • Table 30: Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 31: Cobas 6500 Analyzer - Product Status 22
  • Table 32: Cobas 6500 Analyzer - Product Description 22
  • Table 33: Scanadu HQ Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 34: Scanadu Urine - Product Status 23
  • Table 35: Scanadu Urine - Product Description 23
  • Table 36: Scanadu HQ - Ongoing Clinical Trials Overview 24
  • Table 37: Scanadu Urine - Scanadu Urine Device Validation Study Protocol 25
  • Table 38: Sebia SA Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 39: Capillarys 3 Tera Assay - Urine - Product Status 26
  • Table 40: Capillarys 3 Tera Assay - Urine - Product Description 26
  • Table 41: Capillarys 3 Tera Assay - Urine IT - Product Status 27
  • Table 42: Capillarys 3 Tera Assay - Urine IT - Product Description 27
  • Table 43: Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 44: Clinitek Atlas Next - Product Status 28
  • Table 45: Clinitek Atlas Next - Product Description 28
  • Table 46: Stanford University Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 47: Biostrip Test - Urine Analysis - Product Status 29
  • Table 48: Biostrip Test - Urine Analysis - Product Description 29
  • Table 49: Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 50: Sysmex UX-2000 Integrated Urinalysis Instrument - Product Status 30
  • Table 51: Sysmex UX-2000 Integrated Urinalysis Instrument - Product Description 31
  • Table 52: UC-3500 - Product Status 31
  • Table 53: UC-3500 - Product Description 31
  • Table 54: UF-5000 - Product Status 32
  • Table 55: UF-5000 - Product Description 32
  • Table 56: Teco Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 57: Next Generation Urine Analyzer - Product Status 33
  • Table 58: Next Generation Urine Analyzer - Product Description 33
  • Table 59: Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 60: epiCaPture - Product Status 34
  • Table 61: epiCaPture - Product Description 34
  • Table 62: University of Kentucky Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 63: Diagnostic Gene-Expression Test - Interstitial Cystitis - Product Status 35
  • Table 64: Diagnostic Gene-Expression Test - Interstitial Cystitis - Product Description 35
  • Table 65: Glossary 60

List of Figures

1.2 List of Figures

  • Figure 1: Urine Analysis - Pipeline Products by Stage of Development 7
  • Figure 2: Urine Analysis - Pipeline Products by Segment 8
  • Figure 3: Urine Analysis - Pipeline Products by Territory 9
  • Figure 4: Urine Analysis - Pipeline Products by Regulatory Path 10
  • Figure 5: Urine Analysis - Pipeline Products by Estimated Approval Date 11
  • Figure 6: Urine Analysis - Ongoing Clinical Trials 12
Back to Top